Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/150450
Registo completo
Campo DCValorIdioma
dc.creatorNason, R
dc.creatorBüll, C
dc.creatorKonstantinidi, A
dc.creatorSun, L
dc.creatorYe, Z
dc.creatorHalim, A
dc.creatorDu, W
dc.creatorSørensen, DM
dc.creatorDurbesson, F
dc.creatorFurukawa, S
dc.creatorMandel, U
dc.creatorJoshi, HJ
dc.creatorDworkin, LA
dc.creatorHansen, L
dc.creatorDavid, L
dc.creatorIverson, TM
dc.creatorBensing, BA
dc.creatorSullam, PM
dc.creatorVarki, A
dc.creatorVries, E
dc.creatorHaan, CAM
dc.creatorVincentelli, R
dc.creatorHenrissat, B
dc.creatorVakhrushev, SY
dc.creatorClausen, H
dc.creatorNarimatsu, Y
dc.date.accessioned2023-06-27T13:24:33Z-
dc.date.available2023-06-27T13:24:33Z-
dc.date.issued2021
dc.identifier.issn2041-1723
dc.identifier.urihttps://hdl.handle.net/10216/150450-
dc.description.abstractMucins are a large family of heavily O-glycosylated proteins that cover all mucosal surfaces and constitute the major macromolecules in most body fluids. Mucins are primarily defined by their variable tandem repeat (TR) domains that are densely decorated with different O-glycan structures in distinct patterns, and these arguably convey much of the informational content of mucins. Here, we develop a cell-based platform for the display and production of human TR O-glycodomains (~200 amino acids) with tunable structures and patterns of O-glycans using membrane-bound and secreted reporters expressed in glycoengineered HEK293 cells. Availability of defined mucin TR O-glycodomains advances experimental studies into the versatile role of mucins at the interface with pathogenic microorganisms and the microbiome, and sparks new strategies for molecular dissection of specific roles of adhesins, glycoside hydrolases, glycopeptidases, viruses and other interactions with mucin TRs as highlighted by examples.
dc.description.sponsorshipThis work was supported by the Lundbeck Foundation, the Novo Nordisk Foundation, the European Commission (GlycoImaging H2020-MSCA-ITN-721297, BioCapture H2020-MSCA-ITN-722171), the Danish National Research Foundation (DNRF107), the Mizutani Foundation (to Y.N.), the European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement No 787684 (to C.B.), and the National Institutes of Health grant (R01GM32373 to A.V. and GM137458 to T.M.I.).
dc.language.isoeng
dc.publisherNature Pub. Group
dc.relation.ispartofNature Communications, vol.12(1):4070
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.meshGenetic Engineering
dc.subject.meshGlycosylation
dc.subject.meshHEK293 Cells
dc.subject.meshHumans
dc.subject.meshMicrobiota
dc.subject.meshMucin-1 / genetics
dc.subject.meshMucin-1 / metabolismo
dc.subject.meshMucins / metabolism
dc.subject.meshMucous Membrane / metabolism
dc.subject.meshPolysaccharides / genetics
dc.subject.meshPolysaccharides / metabolism
dc.titleDisplay of the human mucinome with defined O-glycans by gene engineered cells
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.1038/s41467-021-24366-4
dc.relation.publisherversionhttps://www.nature.com/articles/s41467-021-24366-4
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
10.1038-s41467-021-24366-4.pdf3.37 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons